The drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other cancer treatment Opdivo and rival cancer drugs from Roche, Merck and AstraZeneca .
f
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment